PACKAGING KIT

Details for Australian Patent Application No. 2003214106 (hide)

Owner DOSINGER, Stephan SCHMID, Werner

Inventors SCHMID, Werner; DOSINGER, Stephan

Pub. Number AU-A-2003214106

PCT Number PCT/EP03/02360

PCT Pub. Number WO2003/090228

Priority 202 06 232.5 19.04.02 DE

Filing date 7 March 2003

Wipo publication date 3 November 2003

International Classifications

G11B 023/03 Record carriers not specific to the method of recording or reproducing - Containers for flat record carriers

B65D 085/58 Containers, packaging elements or packages, specially adapted for particular articles or materials - for ball bearings, washers, buttons, or like spherical or disc-shaped articles

G11B 033/04 Constructional parts, details or accessories not provided for in the other groups of this subclass - modified to store record carriers

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 202 06 232.5 19.04.02 DE

11 December 2003 Application Open to Public Inspection

  Published as AU-A-2003214106

13 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214107-CG3842 HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS

2003214105-Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states